Newborn Screening Translational Research Network Coordinating Center Duane Alexander, M.D. Director, Eunice Kennedy Shriver National Institute of Child.

Slides:



Advertisements
Similar presentations
Day 2 You receive 2 reports on your desk –The first describes the possibility of expanding the states newborn screening panel to include Severe Combined.
Advertisements

Integrating Child Health Information Systems in Oregon Sherry Spence, MA Oregon Department of Human Services Health Services, Office of Family Health Supported.
ICTS: Strategic Directions for a Winning CTSA Application Gary E. Rosenthal, MD Professor of Internal Medicine and Health Management and Policy Director,
Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
Implementation Research: Using Science to Guide Implementation of Evidence-Based Practices Brian S. Mittman, PhD Director, VA Center for Implementation.
NBSTRN Update NCC/RC PI/PD Meeting November 19, 2010 Michael Watson.
Treuman Katz Center for Pediatric Bioethics Conference Newborn Screening: The Future Revolution Beth A. Tarini, MD, MS Assistant Professor Child.
Recent Expansion of Newborn Screening R. Rodney Howell, M. D. Professor of Pediatrics Miller School of Medicine University of Miami Founding Chair Secretary's.
Integration of Child Health Information Systems (CHIS) Public Health Data Standards Consortium March 2004 Deborah Linzer, MS MCHB/Genetic Services Branch.
Newborn Screening Translational Research Network Goals of the Hunter Kelly Newborn Screening Program Identify, develop and test the most promising technologies.
NSF Data Management Plan Requirements Alex Kanous
NCC Long-Term Follow-Up Project and the NBSTRN CC November 17, 2009 Amy Hoffman, MPH Amy Brower, PhD Project Manager, NBSTRNProject Manager, NCC LTFU.
National Institute on Aging Richard J. Hodes, M.D. Director,NIA/NIH/DHHS ADC Meeting – NIH Roadmap and Budget October 2003.
The NIH Roadmap for Medical Research
Kathryn Camp, M.S., R.D., CSP Consultant to the Office of Dietary Supplements National Institutes of Health Secretary’s Advisory Committee on Heritable.
Ensuring the Quality of Genetic Testing ICORD Meeting September 14, 2007 Lisa Kalman, PhD Coordinator, GeT-RM CDC
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimer’s Disease Drugs: COMET-AD.
Secretary’s Advisory Committee on Heritable Disorders of Newborns and Children September 22, 2011 Newborn Screening Translational Research Network (NBSTRN)
Information Resources and Technology BY deya rejela Baha abbas Information Technology Planning and Management.101 BY deya rejela Baha.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
Treuman Katz Center for Pediatric Bioethics Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor.
THE FRENCH NATIONAL CANCER INSTITUTE (INCa) Focusing care on patients The patient Committee.
Proposed Changes to Advisory Committee Processes Sara Copeland, MD Designated Federal Official Secretary’s Advisory Committee on Heritable Disorders in.
UT Southwestern Center for Translational Medicine Summary Statement Discussion November 14, 2013 Robert D. Toto, M.D. Associate Dean for Clinical and Translational.
Michael F. Huerta, Ph.D. Associate Director for Program Development National Library of Medicine, NIH BD2K CDE Webinar – September 8, 2015 Common Data.
Anticipated FY2016 Appropriations Agency$ Million NIH200 Cancer70 Cohort130 FDA10 Office of the Natl Coord. for Health IT (ONC) 5 TOTAL215 Mission: To.
NBSTRN Update Amy Hoffman, MPH December 1, NBSTRN Structure Newborn Screening Translational Research Network2 NBSTRN CC Michael Watson, PI Barry.
Newborn Screening Translational Research Network Virtual Repository of Dried Blood Spots Investigator Demonstration February 16, 2012 Call in Number: (470)
WATER, WATER EVERYWHERE? The Water Resources Management Committee of the American Public Works Association.
RESEARCH PROGRAM UPDATE Sarah Castro, MPH Senior Research Support Liaison.
Ethical and Regulatory Considerations in Research using Residual Specimens Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate.
Yale Center for Clinical Investigation: Academic Home to the CTSA Secretary’s Advisory Committee on Human Research Protections (SACHRP) Presentation Tesheia.
Chapter Quality Network (CQN) Asthma Pilot Project Our Now and Our Future James C. Wiley, MD, FAAP CQN Chapter Physician Leader Alabama Chapter-AAP President.
The Secretary’s Advisory Committee on Human Research Protections (SACHRP): Recommendations Regarding the Newborn Screening Reauthorization Act of 2014.
West Virginia Clinical Translational Science Institute Links Scientists and Teachers Sara Hanks, Ann Chester, Summer Kuhn.
Joyce Mull, MPM Director, Regulatory Affairs National Surgical Adjuvant Breast and Bowel Project Consent Form and IRB Challenges that Arise with Specimen.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Chapter Quality Network (CQN) Asthma Pilot Project Our Present and Our Future Sandra Miller, MD Oregon Chapter Physician Leader Judy Dolins, MPH Director,
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.
The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.
While most HMORN projects involve two to five Network sites, its largest consortiums are the most widely recognized. Nearly 40% of HMORN projects and consortium.
HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.
Team Building: Critical Role of Interdisciplinary Research Teams in Translational Research C. Kent Osborne, M.D. Director, Lester and Sue Smith Breast.
Newborn Screening Translational Research Network Virtual Repository of Dried Blood Spots Investigator Demonstration March 15, 2012 Call in Number: (415)
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
The NIH/NICHD Funded Newborn Screening Translational Research Network An Project to Develop Infrastructure to Facilitate Research and Clinical Investigation.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
Organizational Funding Portfolios and Beyond: Assessing the Full Research Landscape Panel Session 731 American Evaluation Association EVALUATION 2012 October.
Data Coordinating Center University of Washington Department of Biostatistics Elizabeth Brown, ScD Siiri Bennett, MD.
OVERVIEW OF THE WORKFORCE DEVELOPMENT DOMAIN TASK FORCE APRIL 16, 2015 Joan D. Nagel, M.D., M.P.H. Program Director, Division of Clinical Innovation National.
Newborn Screening: National and International Hurdles and Progress
Translational Research Why should you care about translational research? The public cares. Translation into therapies justifies spending on science.
NIH Clinical Trial Requirements
The Influence of Domain-Specific Metric Development on Evaluation and Design: An Example from National Institutes of Health Technology Development Programs.
Piloting IRBchoice at Vanderbilt
Trial Innovation Network Uncovering Grand Opportunities
Research Overview Jacqueline French, MD Chief Scientific Officer
PCORI Research Priorities and Relevant Examples
What is CICATS? The University of Connecticut, in partnership with regional hospitals, state agencies, and community health care organizations, has.
Clinical and Translational Science Awards Program
Overview of Clinical & Translational Penn
Quality and Process Improvement Program (QPIP)
Trial Funding and Engagement: The NIH Sponsored CTSA Program
WATER, WATER EVERYWHERE?
National Pediatric Critical Care Collaborative Research Network
Partnership for Research and Innovation in the Health System (PRIHS) /2020 Sean Dewitt, Program Manager, Health, Alberta Innovates Marc Leduc,
Presentation transcript:

Newborn Screening Translational Research Network Coordinating Center Duane Alexander, M.D. Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH

Statement of Work/Objectives 1) Establish an organized network of State newborn screening programs and clinical centers - Collect information from state labs and registries that will provide information as well as archival blood spots 2) Develop, implement and refine a national research informatics system for investigators and policy makers that dovetails with the established national clinics network - Informatics system to link researchers with potential subjects for trials - Liaison between researchers and registries, NBS programs and clinical centers - Actively link grantees with technology validation sites

Statement of Work/Objectives 3) Establish and administer an efficient and reliable repository of residual dried blood spots comprised of those stored by State NBS programs and other resources. 4) Provide expertise and support to researchers related to regulatory requirements associated with informed consent, IRBs and state and local research policy associated with NBS. 5) Facilitate research on the development of new methods and technologies by maintaining close contact with the scientific and biomedical research communities.

Statement of Work/Objectives 6) Facilitate research on screened and treated patients to define effectiveness of treatments and long-term outcomes through - Monitoring new approaches to treatment for screened disorders - Encourage and support outcome studies related to newborn screening 7) Provide statistical leadership and clinical trial design expertise for the individualized needs of researchers through the NBSTRN Coordinating Center 8) Facilitate the timely dissemination of research findings

Statement of Work/Objectives 9) Establish a steering committee comprised of knowledgeable healthcare professionals, public health professionals, ethicists and scientists to make recommendations to NIH program regarding research proposals to have access to NBSTRNCC - Review consistent with NIH standards 10) NIH-supported researchers, in conjunction with their Institutes program officer, will nominate research projects for consideration by the network in order to gain access to the NBSTRNCC

Budget FY08 $ 998,9279/08-9/09 FY09$1,874,6309/09-9/10 FY10$2,318,7119/10-9/11 FY11$3,569,5889/11-9/12 FY12$4,737,9159/12-9/13 Total $ 13,499,771

Newborn screening-update Contracts  Newborn Screening Translational Research Network (NBSTRN)  New Technologies in Newborn Screening Lysosomal Storage Disorders; Assay validation PAR: “Innovative Therapies and Clinical Studies for Screenable Disorders” (R01, R03, R21)  Technologies related to therapies for currently screened disorders

Examples of Current Newborn Screening Projects R01 – Spinal Muscular Atrophy – Newborn screening, novel therapies R42 – Turner syndrome and other sex chromosome abnormalities – Screening techniques R44 – Newborn screening blood spot quality control P01 – Newborn screening Fragile X – Family impact. R03 – SCID – Newborn screening